SMNR
Semnur Pharmaceuticals, Inc.Company with tickers: SMNR, SMNRW
CIK
1913577
CUSIP
81686G105
Shares Outstanding
230,209,142
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2025-06-12 | 2025-06-11 | |
| 8-K | 2025-07-11 | — | |
| 8-K | 2025-07-28 | 2025-07-22 | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-15 | 2025-06-30 | |
| 8-K | 2025-08-22 | 2025-08-20 | |
| 8-K | 2025-09-04 | 2025-09-03 | |
| 8-K | 2025-09-26 | 2025-09-22 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-12-03 | — | |
| 10-K | 2026-02-27 | 2025-12-31 | |
| 8-K | 2026-03-17 | 2026-03-13 | |
| 8-K | 2026-04-23 | 2026-04-20 | |
| DEF 14A | 2026-04-30 | 2026-06-25 | |
| 10-Q | 2026-05-13 | 2026-03-31 |
Showing 51–65 of 65 filings